Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 4 Planned sale Director sold 240 shares at an average $550.33 ($132,080)
  2. 4 Planned sale Director sold 18,410 shares at an average $522.40 ($9,617,312)
  3. 144 Insider Sale of Securities
  4. SCHEDULE 13D/A Stake Beneficial Ownership Report
  5. SCHEDULE 13D/A Stake Beneficial Ownership Report
  6. 4 Planned sale Director sold 24,800 shares at an average $552.18 ($13,694,158)
  7. 4 Planned sale Director sold 18,650 shares at an average $552.15 ($10,297,573)
  8. 8-K Event Executive or director change
  9. 144 Insider Sale of Securities
  10. 144 Insider Sale of Securities
  11. 4 Open-market sale President and CEO sold 2,400 shares at $575.34 ($1,380,816)
  12. 144 Insider Sale of Securities
  13. 4 Planned sale EVP and CFO sold 4,173 shares at an average $578.34 ($2,413,416)
  14. 144 Insider Sale of Securities
  15. 4 Planned sale Chief Commercial Officer sold 1,958 shares at an average $553.11 ($1,082,986)
  16. 144 Insider Sale of Securities
  17. 4 Planned sale Director sold 8,500 shares at an average $520.96 ($4,428,198)
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. 144 Insider Sale of Securities
  20. 4 Open-market sale Director sold 16,575 shares at an average $484.30 ($8,027,354)

Page 5 of 62 · 1,224 filings